Skip to content
Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results episode artwork

Jan 31, 2022 46 min

Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results

from Sarcoma Sisters Hosted by Kopp and Allen-Rhoades

Dr. Allen-Rhoades and Dr. Kopp discuss the results of the recently published Ewing Sarcoma clinical trial - Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. We mention in the episode that the full article is accessible, however, it is only if you purchase individually - bummer. However, the link Is here for the article abstract and if you would like to purchase. We discuss the clinical trial in detail including background on previous trials, methods, results and how these results affect current and future treatment of patients with Ewing sarcoma. Thank you for listening and please let us know your thoughts!

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results

0:00 46:03

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Sarcoma Sisters?

This episode is 46 minutes long.

When was this Sarcoma Sisters episode published?

This episode was published on January 31, 2022.

Can I download this Sarcoma Sisters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.